Prognostic Factors of Oligometastasis after Stereotactic Body Radiotherapy: Real-world Utility of the European Society for Radiotherapy and Oncology/European Organisation for Research and Treatment of Cancer Classification
Ryosuke Bessyo,
Haruka Uezono,
Yosuke Ota
et al.
Abstract:Background
The efficacy of local therapy for oligometastatic disease (OMD) remains unclear. This study aimed to evaluate the prognostic utility of the classification system for OMD and explore which groups may benefit from stereotactic body radiation therapy (SBRT).
Methods
The single-center retrospective study included 48 patients (55 sites) with solid tumors and 1–3 extracranial oligometastases, who underwent SBRT for all metastases at our institution between January 2018 and December 2021. OMD states were… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.